Search research articles
Contact Us
Filters
Showing results (251-260 of 305) with videos related to
Page
of 31
Sort By:
Neuro-Oncology
|
February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study
Michael D Prados, W K A Yung, Kurt A Jaeckle, et al.
AJNR. American Journal of Neuroradiology
|
May 30, 2026
Tumor Growth Rate (TGR) Analysis Predicts Survival in a Multicenter Phase II Study of the PARP Inhibitor Pamiparib (BGB-290) with Temozolomide in Recurrent IDH-Mutant Gliomas (ABTC-1801)
Benjamin M Ellingson, Timothy F Cloughesy, Xiaobu Ye, et al.
Neuro-Oncology
|
March 19, 2019
Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines
Susan M Chang, Hans Messersmith, Manmeet Ahluwalia, et al.
Journal of Pain and Symptom Management
|
April 9, 2026
Practical management of headaches in patients with primary and secondary brain tumors
Megan Eh Still, Joy Burke, Jennifer Robblee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2022
Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline
David Schiff, Hans Messersmith, Priscilla K Brastianos, et al.
Journal of Critical Care
|
November 29, 2005
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study
Deborah J Cook, Graeme Rocker, Maureen Meade, et al.
Neuro-Oncology
|
July 31, 2022
EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors
Roberta Rudà, David Capper, Adam D Waldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177
Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Neuro-Oncology
|
January 10, 2015
Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma
Eudocia Q Lee, David A Reardon, David Schiff, et al.
Neuro-Oncology
|
September 22, 2016
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials
Edward K Avila, Marc Chamberlain, David Schiff, et al.
Page
of 31
Search research articles
Search
Showing results (251-260 of 305) with videos related to
Sort By:
Page
of 31
Neuro-Oncology
|
February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study
Michael D Prados, W K A Yung, Kurt A Jaeckle, et al.
AJNR. American Journal of Neuroradiology
|
May 30, 2026
Tumor Growth Rate (TGR) Analysis Predicts Survival in a Multicenter Phase II Study of the PARP Inhibitor Pamiparib (BGB-290) with Temozolomide in Recurrent IDH-Mutant Gliomas (ABTC-1801)
Benjamin M Ellingson, Timothy F Cloughesy, Xiaobu Ye, et al.
Neuro-Oncology
|
March 19, 2019
Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines
Susan M Chang, Hans Messersmith, Manmeet Ahluwalia, et al.
Journal of Pain and Symptom Management
|
April 9, 2026
Practical management of headaches in patients with primary and secondary brain tumors
Megan Eh Still, Joy Burke, Jennifer Robblee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2022
Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline
David Schiff, Hans Messersmith, Priscilla K Brastianos, et al.
Journal of Critical Care
|
November 29, 2005
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study
Deborah J Cook, Graeme Rocker, Maureen Meade, et al.
Neuro-Oncology
|
July 31, 2022
EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors
Roberta Rudà, David Capper, Adam D Waldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177
Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Neuro-Oncology
|
January 10, 2015
Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma
Eudocia Q Lee, David A Reardon, David Schiff, et al.
Neuro-Oncology
|
September 22, 2016
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials
Edward K Avila, Marc Chamberlain, David Schiff, et al.
Page
of 31